COVID-19 vaccine hesitancy and acceptance in patients with multiple myeloma: A national multicenter survey in China

QR Code

COVID-19 vaccine hesitancy and acceptance in patients with multiple myeloma: A national multicenter survey in China

Objective: To investigate factors influencing vaccine hesitancy and its effects on SARS-CoV-2 infection in multiple myeloma (MM) patients during the Omicron BA.4/5 subvariant outbreak. Methods: This cross-sectional study was conducted in mainland China from December 26, 2022, to April 20, 2023. An e...

Full description

Saved in:

Bibliographic Details
Main Authors:	Huiwen He, Xianghong Jin, Ziping Li, Shuangjiao Liu, Wenming Chen, Wanling Sun, Baolai Hua, Yongzhe Li, Junling Zhuang
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2025-06-01
Series:	Asian Pacific Journal of Tropical Medicine
Subjects:	questionnaire multiple myeloma vaccination sars-cov-2 outbreak infection
Online Access:	https://journals.lww.com/10.4103/apjtm.apjtm_398_24
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pomalidomide in relapsed and refractory multiple myeloma: multicenter retrospective study
by: V. G. Potapenko, et al.
Published: (2022-07-01)

IMMUNE DISTURBANCES IN PATIENTS WITH MULTIPLE MYELOMA
by: E. A. Senkina, et al.
Published: (2014-07-01)

DIAGNOSTIC OF NONSECRETORY MULTIPLE MYELOMA (CLINICAL CASE)
by: N. T. Vatutin, et al.
Published: (2017-03-01)

Whole-body low-dose computed tomography in primary patients with multiple myeloma
by: A. M. Danilina, et al.
Published: (2023-05-01)

The multicenter experience with bendamustine in the treatment of relapsed and refractory multiple myeloma
by: S. V. Voloshin, et al.
Published: (2015-10-01)

Pitfalls in the pathological diagnosis of multiple myeloma
by: V. V. Baykov
Published: (2022-11-01)

Nestin in multiple myeloma: emerging insights into a potential therapeutic target
by: Yingmiao Wu, et al.
Published: (2025-07-01)

Cariohemodynamics in patients with multiple myeloma depending on renal function
by: B. B. Samura, et al.
Published: (2019-12-01)

Neutrophilic hyperleukocytosis in the multiple myeloma onset
by: I. G. Rekhtina, et al.
Published: (2022-07-01)

Infectious complications in patients with multiple myeloma on first chemotherapy cycle
by: A. A. Novikova, et al.
Published: (2018-10-01)

Efficiency of pomalidomide therapy in patients with multiple myeloma refractory to lenalidomide
by: I. G. Rekhtina, et al.
Published: (2019-04-01)

How to Diagnose, Treat, and Monitor Treatment Response in Patients with Multiple Myeloma
by: Wulyo Rajabto, et al.
Published: (2022-09-01)

Multiple Myeloma in the Practice of a Primary Care Physician: A Clinical Case
by: A. E. Shklyaev, et al.
Published: (2020-06-01)

Bortezomib neurotoxicity treatment of multiple myeloma: single center experience and literature review
by: N. V. Stepanova, et al.
Published: (2022-11-01)

A case of multiple myeloma presenting with bullous skin lesions as the initial symptom
by: CHEN Lin, et al.
Published: (2025-04-01)

PHARMACOECONOMIC ANALYSIS OF THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD
by: A. S. Kolbin, et al.
Published: (2015-03-01)

CHARACTERISTICS OF NEUTROPHIL CHEMILUMINESCENCE IN PATIENTS WITH TYPE G MULTIPLE MYELOMA AT DIFFERENT STAGES OF THE DISEASE
by: O. V. Smirnova, et al.
Published: (2016-01-01)

Incidence, characteristics, and treatments of peripheral neuropathy in multiple myeloma patients receiving bortezomib (velcade)
by: S. S. Bessmeltsev, et al.
Published: (2022-11-01)

Impact of treatment delay of multiple myeloma bone disease on later myeloma-related skeletal events and outcome
by: Eskelinen Veera, et al.
Published: (2025-08-01)

Results of multiple myeloma treatment with bortezomib
by: T. I. Pospelova, et al.
Published: (2022-11-01)

A study to identify novel biomarkers associated with multiple myeloma
by: Bhaskar Kalarani Iyshwarya, et al.
Published: (2023-11-01)

Pomalidomide for the management of relapsed and refractory multiple myeloma: a case report and review of literature
by: S. V. Semochkin
Published: (2015-10-01)

New proteasome inhibitors in the management of multiple myeloma
by: S. V. Semochkin
Published: (2019-07-01)

Pain syndrome in multiple myeloma (results of a single-center study)
by: M. V. Soloveva, et al.
Published: (2024-09-01)

Prevention and management of bortezomib-induced peripheral neuropathy in patients with multiple myeloma
by: S. V. Semochkin, et al.
Published: (2022-04-01)

The role of TNF-? in the pathogenesis of multiple myeloma “a study in Iraqi patients”
by: Baghdad Science Journal
Published: (2014-06-01)

Lenalidomide versus lenalidomide + dexamethasone prolonged treatment after second‐line lenalidomide + dexamethasone induction in multiple myeloma
by: Johan Lund, et al.
Published: (2018-06-01)

Dynamic changes in γδT cells and bone resorption markers after zoledronic acid in multiple myeloma: A prospective study
by: Chao-Hung Wei, et al.
Published: (2025-07-01)

The clinical case of cardiac amyloidosis associated with multiple myeloma
by: E. I. Tsoi, et al.
Published: (2020-07-01)

Non-secretory myeloma: clinical profile and diagnostic utility of immunohistochemistry and free light chain assay in a rare variant of plasma cell myeloma
by: Monal Trisal, et al.
Published: (2025-04-01)

Treatment of bone complications in multiple myeloma patients
by: V. V. Ptushkin
Published: (2022-11-01)

MORPHOLOGICAL FEATURES OF TUMORS SUBSTRATE IN MULTIPLE MYELOMA PATIENTS COMPLICATED WITH PLASMACYTOMA
by: M. V. Firsova, et al.
Published: (2018-07-01)

EPIDEMIOLOGY OF MULTIPLE MYELOMA ACCORDING TO THE КIROV REGION POPULATION REGISTERS
by: A. S. Luchinin, et al.
Published: (2017-10-01)

Antitumor treatment and cardiohemodynamics in patients with multiple myeloma depending on renal function
by: B. B. Samura, et al.
Published: (2020-08-01)

Prognosis of multiple myeloma patients based on histopathological evaluation of bone marrow
by: Niloofar Arefi Sigaroudi, et al.
Published: (2025-06-01)

Differences in interactions with the bone microenvironment between solid tumors and multiple myeloma: pathogenetic aspects. Possibilities and effectiveness of osteomodifying agents in multiple myeloma
by: A. V. Snegovoy, et al.
Published: (2021-04-01)

Ferroptosis: a novel pharmacological mechanism against multiple myeloma
by: Jingbo Shi, et al.
Published: (2025-07-01)

Multiple myeloma with extramedullary plasmacytoma: pathogenesis and clinical case
by: M. V. Firsova, et al.
Published: (2022-11-01)

Multiple myeloma and cardiovascular risk (a literature review)
by: B. B. Samura, et al.
Published: (2020-11-01)

A Rare Case of Classical Multiple Myeloma Presenting as Cavernous Sinus Syndrome
by: Yusuf Hallak, et al.
Published: (2025-06-01)